domingo, 27 de noviembre de 2016

Genetic screening for neovascular AMD: cost effective…not so quick. - PubMed - NCBI

Genetic screening for neovascular AMD: cost effective…not so quick. - PubMed - NCBI
 2015 Dec 15;1:24. eCollection 2015.

Genetic screening for neovascular AMD: cost effective…not so quick.

Abstract

The following is a response to Brown and colleagues (Int J Retin Vitr 1:19, 2015), who analyzed the cost effectiveness of genetic screening for neovascular AMD in Category 3 (intermediate). As explained in this letter, it is premature to propose that genetic screening is cost effective in this setting. A simple clinical history and macular exam is highly cost effective and can easily guide screening strategies.
PMID:
 
27847617
 
PMCID:
 
PMC5088460
 
DOI:
 
10.1186/s40942-015-0024-5
[PubMed - in process] 
Free PMC Article